News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
788,849 Results
Type
Article (65534)
Company Profile (687)
Press Release (722628)
Multimedia
Podcasts (107)
Webinars (12)
Section
Business (223196)
Career Advice (2951)
Deals (38229)
Drug Delivery (122)
Drug Development (87453)
Employer Resources (183)
FDA (17523)
Job Trends (16751)
News (378061)
Policy (36724)
Tag
Academia (2953)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (94)
Alliances (54408)
ALS (98)
Alzheimer's disease (1482)
Antibody-drug conjugate (ADC) (147)
Approvals (17501)
Artificial intelligence (288)
Autoimmune disease (26)
Automation (16)
Bankruptcy (386)
Best Places to Work (12593)
BIOSECURE Act (22)
Biosimilars (117)
Biotechnology (473)
Bladder cancer (83)
Brain cancer (30)
Breast cancer (296)
Cancer (2388)
Cardiovascular disease (197)
Career advice (2469)
Career pathing (33)
CAR-T (167)
Cell therapy (463)
Cervical cancer (21)
Clinical research (70725)
Collaboration (901)
Compensation (542)
Complete response letters (29)
COVID-19 (2814)
CRISPR (47)
C-suite (259)
Cystic fibrosis (107)
Data (2256)
Decentralized trials (2)
Denatured (30)
Depression (53)
Diabetes (288)
Diagnostics (6862)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (130)
Drug pricing (118)
Drug shortages (30)
Duchenne muscular dystrophy (97)
Earnings (92627)
Editorial (44)
Employer branding (22)
Employer resources (156)
Events (125265)
Executive appointments (773)
FDA (18832)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (800)
Gene editing (115)
Generative AI (26)
Gene therapy (338)
GLP-1 (821)
Government (4937)
Grass and pollen (6)
Guidances (59)
Healthcare (20724)
Huntington's disease (25)
IgA nephropathy (30)
Immunology and inflammation (140)
Indications (30)
Infectious disease (2971)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (56)
Intellectual property (100)
Interviews (512)
IPO (17465)
IRA (50)
Job creations (4647)
Job search strategy (2100)
Kidney cancer (11)
Labor market (39)
Layoffs (532)
Leadership (22)
Legal (9082)
Liver cancer (81)
Lung cancer (335)
Lymphoma (157)
Machine learning (7)
Management (64)
Manufacturing (339)
MASH (72)
Medical device (14485)
Medtech (14490)
Mergers & acquisitions (21315)
Metabolic disorders (760)
Multiple sclerosis (85)
NASH (22)
Neurodegenerative disease (107)
Neuropsychiatric disorders (33)
Neuroscience (2074)
NextGen: Class of 2025 (7520)
Non-profit (5058)
Now hiring (40)
Obesity (408)
Opinion (269)
Ovarian cancer (78)
Pain (97)
Pancreatic cancer (86)
Parkinson's disease (160)
Partnered (22)
Patents (247)
Patient recruitment (114)
Peanut (51)
People (63079)
Pharmaceutical (139)
Pharmacy benefit managers (21)
Phase I (21935)
Phase II (30852)
Phase III (23270)
Pipeline (1226)
Policy (165)
Postmarket research (3080)
Preclinical (9636)
Press Release (72)
Prostate cancer (112)
Psychedelics (35)
Radiopharmaceuticals (268)
Rare diseases (420)
Real estate (6992)
Recruiting (69)
Regulatory (24971)
Reports (47)
Research institute (2628)
Resumes & cover letters (471)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (79)
Series A (138)
Series B (90)
Service/supplier (29)
Sickle cell disease (57)
Special edition (18)
Spinal muscular atrophy (161)
Sponsored (30)
Startups (4048)
State (2)
Stomach cancer (15)
Supply chain (74)
Tariffs (44)
The Weekly (75)
Vaccines (767)
Venture capitalists (43)
Weight loss (287)
Women's health (35)
Worklife (18)
Date
Today (184)
Last 7 days (916)
Last 30 days (2801)
Last 365 days (35133)
2025 (11327)
2024 (37658)
2023 (42394)
2022 (53778)
2021 (58581)
2020 (57529)
2019 (51030)
2018 (38725)
2017 (35426)
2016 (35608)
2015 (41764)
2014 (36892)
2013 (33868)
2012 (33972)
2011 (34472)
2010 (33381)
Location
Africa (993)
Alabama (59)
Alaska (7)
Arizona (258)
Arkansas (14)
Asia (45617)
Australia (7888)
California (6393)
Canada (2051)
China (556)
Colorado (281)
Connecticut (301)
Delaware (157)
Europe (102840)
Florida (937)
Georgia (218)
Hawaii (1)
Idaho (62)
Illinois (600)
India (29)
Indiana (329)
Iowa (12)
Japan (167)
Kansas (110)
Kentucky (27)
Louisiana (14)
Maine (70)
Maryland (958)
Massachusetts (4912)
Michigan (244)
Minnesota (419)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (65)
New Hampshire (69)
New Jersey (1810)
New Mexico (30)
New York (1813)
North Carolina (1126)
North Dakota (9)
Northern California (2734)
Ohio (218)
Oklahoma (15)
Oregon (48)
Pennsylvania (1416)
Puerto Rico (13)
Rhode Island (36)
South America (1380)
South Carolina (23)
South Dakota (1)
Southern California (2372)
Tennessee (104)
Texas (958)
United States (24563)
Utah (191)
Virginia (169)
Washington D.C. (68)
Washington State (604)
West Virginia (3)
Wisconsin (69)
788,849 Results for "enzon pharmaceuticals inc bridgewater new jersey".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
New Jersey’s Life Sciences Scene Continues Expanding Beyond Big Pharma
Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more small and midsize life sciences businesses. Choose New Jersey, Grace Therapeutics and Onyx Equities executives discuss the state’s life sciences scene.
April 10, 2025
·
6 min read
·
Angela Gabriel
Layoffs
Eisai Will Trim About 7% of US Workforce, Including New Jersey Employees
Eisai’s cuts will affect 121 employees across the Japanese company’s U.S. operations, including 57 people at its American headquarters in Nutley, New Jersey. A company spokesperson said the pharma remains fully committed to the U.S. market.
February 28, 2025
·
1 min read
·
Angela Gabriel
Job Trends
8 Companies Hiring in New Jersey
Looking for a biopharma job in New Jersey? Check out the
BioSpace
list of eight companies hiring life sciences professionals like you.
January 23, 2025
·
2 min read
·
Angela Gabriel
Layoffs
Organon Lets Go of 93 Employees in New Jersey in Continuing Workforce Cuts
Organon’s workforce cuts come several months after the company’s loss of exclusivity to its second-largest product, Atozet.
April 1, 2025
·
2 min read
·
Angela Gabriel
ProBio Expands Plasmid DNA and Viral Vector Production in New Jersey to Accelerate Delivery of Life-Changing Cell and Gene Therapies
ProBio Inc, a New Jersey-based contract development and manufacturing organization (CDMO), proudly announce the expansion of its plasmid DNA and viral vector manufacturing capabilities with the opening of a new state-of-the-art facility in Hopewell, New Jersey.
June 25, 2024
·
2 min read
Press Releases
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science’s Biggest Challenges
November 15, 2024
·
2 min read
Press Releases
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals
February 27, 2025
·
3 min read
Job Trends
5 Top Companies Hiring in New Jersey
Looking for a biopharma job in New Jersey? Check out the BioSpace list of five top companies hiring life sciences professionals like you.
March 27, 2024
·
1 min read
·
Angela Gabriel
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces FDA Award of Filing Fee Waiver for Upcoming NRX-100 (preservative free ketamine) New Drug Application to Treat Patients with Suicidal Depression
May 1, 2025
·
7 min read
Pharm Country
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
Citius Pharmaceuticals, Inc. today announced that the Company has received $2.4 million in non-dilutive capital.
March 7, 2024
·
5 min read
1 of 78,885
Next
